The pro-inflammatory mediators directly correlate with inducible nitric oxide synthase (NOS2), which is an emerging biomarker of aggressive tumours that predicts poor survival in patients with elevated tumour NOS2 expression [49,50,51]. Here, NOS2 is linked to neoplasm.